What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...
Multimodality imaging can identify papillary muscles that are the source of arrhythmias. Increased echogenicity, gadolinium enhancement, and calcifications on papillary muscles can indicate site of ...
Early increases in CRP during immune checkpoint inhibitor (ICI) therapy are linked to a higher risk of venous thromboembolism (VTE). CRP trajectories could serve as biomarkers for assessing VTE risk ...
The following are key points to remember from a state-of-the-art review on cardiovascular (CV) risk in prostate cancer (PC): ...
Chlorthalidone is not superior to hydrochlorothiazide in preventing kidney disease progression in patients with hypertension. Chlorthalidone causes slightly more hypokalemia than hydrochlorothiazide.
The following are key points to remember from a review on nonsurgical management of chronic venous insufficiency (CVI): ...
The TCW trial showed that in patients with severe aortic stenosis and complex CAD, FFR-guided PCI plus TAVI resulted in fewer deaths and major bleeding events compared with combined SAVR plus CABG at ...
In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...
In the RESHAPE-HF2 trial, 505 patients with systolic HF (left ventricular ejection fraction 20-50% and New York Heart Association [NYHA] class II-IV HF symptoms) and moderate to severe functional MR ...
In elderly US veterans, higher AHA Life’s Essential (LE8) component scores were associated a 75% lower risk of ASCVD, likelihood of developing MACE, and incidence of all-cause mortality. The ...
In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050. He then discusses consensus ...
The U.S. Senate passed the Cardiomyopathy Health Education, Awareness, Research, and Training in the Schools (HEARTS) Act (H.R. 6829), a major ACC Advocacy priority, on Dec. 10. The bill secures ...